Guo Tong Xu
Director/Board Member bei ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD.
Aktive Positionen von Guo Tong Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Director/Board Member | 28.08.2020 | - |
Independent Dir/Board Member | 28.08.2020 | - | |
GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Director/Board Member | 01.06.2018 | - |
Independent Dir/Board Member | 01.06.2018 | - | |
GRACELL BIOTECHNOLOGIES INC. | Director/Board Member | 01.02.2019 | - |
Independent Dir/Board Member | 01.02.2019 | - | |
Tongji University | Corporate Officer/Principal | 01.01.2008 | - |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Director/Board Member | 01.07.2022 | - |
Independent Dir/Board Member | 01.07.2022 | - |
Karriereverlauf von Guo Tong Xu
Ehemalige bekannte Positionen von Guo Tong Xu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CELLULAR BIOMEDICINE GROUP, INC. | Director/Board Member | 07.11.2014 | 11.11.2016 |
Independent Dir/Board Member | 07.11.2014 | 11.11.2016 | |
Temple University School of Medicine | Corporate Officer/Principal | 01.03.2008 | 01.07.2016 |
Ausbildung von Guo Tong Xu
Harbin Medical University | Undergraduate Degree |
University of North Texas Health Science Center | Doctorate Degree |
Chinese Academy of Medical Sciences | Doctorate Degree |
Peking Union Medical College | Doctorate Degree |
Statistik
International
China | 8 |
Vereinigte Staaten | 4 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 5 |
Doctorate Degree | 3 |
Sektoral
Consumer Services | 7 |
Health Technology | 4 |
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
GUANGZHENG EYE HOSPITAL GROUP CO.,LTD. | Health Services |
Private Unternehmen | 3 |
---|---|
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Gracell Biotechnologies, Inc.
Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer. The company was founded by Wei Cao in May 2017 and is headquartered in Suzhou, China. | Health Technology |
- Börse
- Insiders
- Guo Tong Xu
- Erfahrung